MEDICUS PHARMA LTD. Secured Long-term Debt, Noncurrent
MEDICUS PHARMA LTD. (MDCX) had Secured Long-term Debt, Noncurrent of $17.98 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:SecuredLongTermDebt · last filed 2026-08-12
- 2026-06-30: Secured Long-term Debt, Noncurrent $17.98M.
- 2025-12-31: Secured Long-term Debt, Noncurrent $0.00.
| Period end | Secured Long-term Debt, Noncurrent |
|---|---|
| 2026-06-30 | $17.98M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |